Citigroup
BIOA

Citigroup’s BioAge Labs BIOA Stock Holding History

Citigroup’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$747K Buy
30,472
+17,088
+128% +$309K ﹤0.01% 3658
2026
Q1 		$234K Buy
13,384
+11,846
+770% +$228K ﹤0.01% 3939
2025
Q4 		$20.3K Buy
1,538
+1,262
+457% +$11.2K ﹤0.01% 4867
2025
Q3 		$1.62K Sell
276
-10,882
-98% -$51K ﹤0.01% 5534
2025
Q2 		$46.1K Buy
11,158
+2,621
+31% +$10.6K ﹤0.01% 4803
2025
Q1 		$32.1K Sell
8,537
-1,018
-11% -$4.71K ﹤0.01% 4996
2024
Q4 		$55.3K Buy
+9,555
New +$165K ﹤0.01% 5060

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Citigroup's BIOA Position: Q2 2026 in Review

Citigroup increased its BioAge Labs (BIOA) stake by 128% in Q2 2026, buying an estimated $309K and bringing the position to 30,472 shares worth $747K. The position accounts for ﹤0.01% of the portfolio, ranked #3658.

Citigroup first reported a position in BIOA in Q4 2024 and has held it in 7 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Citigroup held 30,472 shares of BioAge Labs worth $747K as of Q2 2026.
  • Citigroup bought 17,088 BioAge Labs shares in Q2 2026, an estimated $309K.
  • BioAge Labs made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3658 holding.
  • Citigroup first reported a position in BioAge Labs in Q4 2024 and has held it in 7 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.